Latest Cost-Benefit Suit Puts CFTC In Uncharted Waters

Law360, New York (November 9, 2012, 5:53 PM EST) -- A suit filed Thursday attacking the U.S. Commodity Futures Trading Commission’s cost-benefit analysis of a Dodd-Frank Act swaps rule follows a well-worn path, but attorneys say the agency faces a new and potentially damaging claim this time around: that it didn’t conduct the analysis at all.

The suit by the CME Group Inc., launched in Washington federal court, seeks to block a Dodd-Frank rule that requires CFTC-registered derivatives-clearing organizations like CME to provide nonpublic reports on cleared swaps deals to a new type of CFTC-registered entity...
To view the full article, register now.